Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies

Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies



Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies
Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.


www.marketwatch.com
#Lilly #Mounjaro #Zepbound #sales #doubled #stock #rallies

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *